{"id":"https://openalex.org/W2322011614","doi":"https://doi.org/10.5414/cpp41241","title":"Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia","display_name":"Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia","publication_year":2003,"publication_date":"2003-06-01","ids":{"openalex":"https://openalex.org/W2322011614","doi":"https://doi.org/10.5414/cpp41241","mag":"2322011614","pmid":"https://pubmed.ncbi.nlm.nih.gov/12816176"},"language":"en","primary_location":{"id":"doi:10.5414/cpp41241","doi":"https://doi.org/10.5414/cpp41241","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cpp41241","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028395075","display_name":"Jan Kowalski","orcid":"https://orcid.org/0000-0001-6455-4502","observed_orcids":["https://orcid.org/0000-0001-6455-4502"]},"institutions":[{"id":"https://openalex.org/I166182418","display_name":"Medical University of Silesia","ror":"https://ror.org/005k7hp45","country_code":"PL","type":"education","lineage":["https://openalex.org/I166182418"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"J. Kowalski","raw_affiliation_strings":["Department of Clinical Pharmacology, Medical University of Silesia, Katowice, Medyk\u00f3w, Poland. farmklin@infomed.slam.katowice.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Medical University of Silesia, Katowice, Medyk\u00f3w, Poland. farmklin@infomed.slam.katowice.pl","institution_ids":["https://openalex.org/I166182418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009237297","display_name":"Bogus\u0142aw Okopie\u0144","orcid":"https://orcid.org/0000-0001-7228-2906","observed_orcids":["https://orcid.org/0000-0001-7228-2906"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Okopien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044530149","display_name":"Andrzej Madej","orcid":"https://orcid.org/0000-0002-7626-0840","observed_orcids":["https://orcid.org/0000-0002-7626-0840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Madej","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110049778","display_name":"M Zieli\u0144ski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Zielinski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068821373","display_name":"Dariusz Belowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Belowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020168295","display_name":"Zbigniew Kalina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z. Kalina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110401283","display_name":"Zbigniew S. Herman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z.S. Herman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0346,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.92382246,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"41","issue":"06","first_page":"241","last_page":"247"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.013700000010430813,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.9769999980926514},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":1.0},{"id":"https://openalex.org/keywords/sicam-1","display_name":"sICAM-1","score":0.8460000157356262},{"id":"https://openalex.org/keywords/mcp-1","display_name":"MCP-1","score":0.871999979019165},{"id":"https://openalex.org/keywords/hyperlipoproteinemia","display_name":"hyperlipoproteinemia","score":0.7900000214576721},{"id":"https://openalex.org/keywords/cell-adhesion-molecules","display_name":"adhesion molecules","score":0.7429999709129333},{"id":"https://openalex.org/keywords/low-fat-diet","display_name":"low-fat diet","score":0.7960000038146973},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.828000009059906},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.7990000247955322},{"id":"https://openalex.org/keywords/endothelial-inflammation","display_name":"endothelial inflammation","score":0.6039999723434448},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.5920000076293945},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.9340000152587891},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.4729999899864197},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9319999814033508}],"concepts":[{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.9660854339599609},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.9451150894165039},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6554968953132629},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6528122425079346},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5864659547805786},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.4404746890068054},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.36336028575897217}],"mesh":[{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000178","qualifier_name":"diet therapy","is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018799","descriptor_name":"Intercellular Adhesion Molecule-1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D018932","descriptor_name":"Chemokine CCL2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5414/cpp41241","doi":"https://doi.org/10.5414/cpp41241","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cpp41241","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:12816176","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12816176","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1989014683","https://openalex.org/W2360376192","https://openalex.org/W2335185901","https://openalex.org/W2000769605","https://openalex.org/W2102267426","https://openalex.org/W2015390987","https://openalex.org/W2394309718","https://openalex.org/W2198621908","https://openalex.org/W7096482861","https://openalex.org/W2002638829"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,32,100,135,295,330],"most":[2],"important":[3],"mechanism":[4],"through":[5],"which":[6,278],"high":[7,302],"plasma":[8,53,65,136,328],"lipid":[9,303,350],"levels":[10,139,171,200,240,255,268,287,304,309,322,336,351,375],"trigger":[11],"the":[12,21,149,154,192,222,267,286,321,335,358,374],"formation":[13],"of":[14,23,34,43,49,131,269,288,297,310,323,337,357,376],"atherosclerotic":[15],"lesions":[16],"involves":[17],"a":[18,86,117,128,248,263,282,346,354,371],"change":[19],"in":[20,175,205,253,258,262,266,285,334,349,373],"expression":[22],"adhesion":[24,137,155,377],"molecules":[25,325],"on":[26,360],"endothelial":[27,361],"and":[28,45,51,63,147,162,177,184,207,214,238,275,291,312,314,340],"smooth":[29,363],"muscle":[30,364],"cells.":[31],"aim":[33],"this":[35,298],"study":[36,299],"was":[37,125,279],"to":[38,85,127,370],"evaluate":[39,153],"an":[40,143],"extralipid":[41],"effect":[42],"fenofibrate":[44,93],"simvastatin":[46],"by":[47,142,281,307],"examination":[48],"MCP-1":[50,62,199,239,292,313,341],"ICAM-1":[52,64,339],"concentration":[54,66],"after":[55,67,148],"1-month":[56,68],"hypolipemic":[57],"therapy":[58,69,317],"as":[59,61],"well":[60],"with":[70,77,91,111,116,165,191,221,327],"low-fat":[71,87,118],"diet":[72,119],"alone.":[73],"METHODS:":[74],"Twenty":[75],"patients":[76,110,161,179,209],"HLPIIb":[78,178,208],"or":[79,94,366],"HLPIIa,":[80],"who":[81],"did":[82],"not":[83,353],"respond":[84],"diet,":[88],"were":[89,113,140,172,201],"treated":[90,115],"micronized":[92],"simvastatin,":[95],"respectively,":[96],"for":[97,120],"1":[98,121],"month.":[99,122],"control":[101,129,163,193,223],"group":[102,124,130,194,224],"included":[103],"18":[104],"normo-lipidemic,":[105],"healthy":[106,133],"age-matched":[107],"participants;":[108],"10":[109,132],"HLPIIa":[112,176,206],"effectively":[114],"This":[123],"compared":[126,190,220,326],"subjects.":[134],"molecule":[138,156],"measured":[141],"ELISA":[144],"method":[145],"before":[146],"treatment.":[150],"To":[151],"accurately":[152],"levels,":[157],"we":[158],"excluded":[159],"hyperlipidemic":[160],"subjects":[164],"any":[166],"inflammatory":[167],"disease.":[168],"RESULTS:":[169],"sICAM-1":[170,235,254,289,311],"significantly":[173,203,233],"higher":[174,204],"(331":[180],"+/-":[181,186,196,211,216,226],"19":[182],"ng/ml":[183],"423":[185],"23":[187],"ng/ml,":[188],"respectively)":[189,219],"(236":[195],"12":[197],"mg/ml).":[198],"also":[202],"(170":[210],"9":[212],"pg/ml":[213],"183":[215],"15":[217],"pg/ml,":[218],"(100":[225],"4":[227],"pg/ml).":[228],"Fenofibrate":[229],"(200":[230],"mg":[231,245],"daily)":[232,246],"decreased":[234],"(by":[236,241,251],"17%)":[237],"12.5%).":[242],"Simvastatin":[243],"(20":[244],"caused":[247],"significant":[249,264,283],"decrease":[250,265,284,333,348,372],"10.5%)":[252],"only.":[256],"Restriction":[257],"dietary":[259],"lipids":[260],"resulted":[261],"cholesterol":[270,273],"(8%),":[271],"LDL":[272],"(14.9%)":[274],"ApoB":[276],"(12.7%),":[277],"accompanied":[280,306],"(8.7%)":[290],"(16.1%).":[293],"CONCLUSION:":[294],"results":[296],"suggest":[300],"that":[301,315,343,368],"are":[305],"increased":[308],"hypolipidemic":[316,331],"only":[318],"slightly":[319],"decreases":[320],"these":[324],"lipids.":[329],"diet-related":[332],"lipids,":[338],"suggests":[342],"it":[344],"is":[345],"drug-induced":[347],"but":[352],"direct":[355],"action":[356],"drugs":[359],"cells,":[362],"cells":[365],"macrophages":[367],"leads":[369],"molecules.":[378]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}